London Centre for Nanotechnology, University College London, London WC1H 0AH, UK.
Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Biomolecules. 2021 Oct 12;11(10):1503. doi: 10.3390/biom11101503.
G-protein coupled receptors (GPCRs) are known to form homo- and hetero- oligomers which are considered critical to modulate their function. However, studying the existence and functional implication of these complexes is not straightforward as controversial results are obtained depending on the method of analysis employed. Here, we use a quantitative single molecule super-resolution imaging technique named qPAINT to quantify complex formation within an example GPCR. qPAINT, based upon DNA-PAINT, takes advantage of the binding kinetics between fluorescently labelled DNA imager strands to complementary DNA docking strands coupled to protein targeting antibodies to quantify the protein copy number in nanoscale dimensions. We demonstrate qPAINT analysis via a novel pipeline to study the oligomerization of the purinergic receptor Y2 (P2Y), a rhodopsin-like GPCR, highly expressed in the pancreatic cancer cell line AsPC-1, under control, agonistic and antagonistic conditions. Results reveal that whilst the density of P2Y receptors remained unchanged, antagonistic conditions displayed reduced percentage of oligomers, and smaller numbers of receptors in complexes. Yet, the oligomeric state of the receptors was not affected by agonist treatment, in line with previous reports. Understanding P2Y oligomerization under agonistic and antagonistic conditions will contribute to unravelling P2Y mechanistic action and therapeutic targeting.
G 蛋白偶联受体(GPCRs)已知形成同型和异型寡聚体,这些寡聚体被认为对调节其功能至关重要。然而,研究这些复合物的存在和功能意义并不简单,因为根据所采用的分析方法,会得到有争议的结果。在这里,我们使用一种名为 qPAINT 的定量单分子超分辨率成像技术来量化示例 GPCR 中的复合物形成。qPAINT 基于 DNA-PAINT,利用荧光标记的 DNA 成像链与偶联至蛋白靶向抗体的互补 DNA 对接链之间的结合动力学,在纳米尺度上定量蛋白质拷贝数。我们通过一种新的分析管道来展示 qPAINT 分析,以研究嘌呤能受体 Y2(P2Y)的寡聚化,P2Y 是一种富含在胰腺癌细胞系 AsPC-1 中的视紫红质样 GPCR,在对照、激动剂和拮抗剂条件下。结果表明,虽然 P2Y 受体的密度保持不变,但拮抗剂条件下显示出较少的寡聚体百分比和较少的受体复合物。然而,激动剂处理并没有影响受体的寡聚状态,这与之前的报道一致。理解激动剂和拮抗剂条件下的 P2Y 寡聚化将有助于揭示 P2Y 的作用机制和治疗靶向。